05/14/2024
7:09 AM | Xilio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
6:45 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
11:15 PM | Xilio Therapeutics (Filer)
| Form EFFECT | |
04/30/2024
4:09 PM | Xilio Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/15/2024
8:00 AM | Xilio Therapeutics (Filer)
| Form 424B5 | |
04/05/2024
3:31 PM | GILEAD SCIENCES, INC. (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G | |
04/05/2024
1:51 PM | Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G/A | |
|
04/03/2024
5:48 PM | GILEAD SCIENCES, INC. (Reporting)
Xilio Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
5:50 PM | GILEAD SCIENCES, INC. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:15 PM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:20 PM | Xilio Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
3:08 PM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
6:55 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:12 PM | Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G | |
02/09/2024
3:33 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates XI, L.P. (Reporting)
Atlas Venture Associates XI, LLC (Reporting)
Atlas Venture Fund XI, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:01 PM | Octagon Capital Advisors LP (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G/A | |
01/19/2024
3:30 PM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
5:16 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates XI, L.P. (Reporting)
Atlas Venture Associates XI, LLC (Reporting)
Atlas Venture Fund XI, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:38 PM | Frankenfield Christopher James (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:15 PM | Russo Rene (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:15 PM | Brennan Kevin M. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:15 PM | Luptakova Katarina (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
6:45 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
3:26 PM | Luptakova Katarina (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
3:23 PM | Luptakova Katarina (Reporting)
Xilio Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2023
7:35 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2023
7:45 PM | Russo Rene (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
7:30 PM | Huber Martin H. Jr. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
7:35 PM | Brennan Kevin M. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
7:40 PM | Frankenfield Christopher James (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
6:40 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
6:45 AM | Xilio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
3:15 PM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
3:30 PM | Clancy Paul J (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:30 PM | Rossi Christina (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:30 PM | Bonstein Sara (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:30 PM | Xilio Therapeutics (Issuer)
Xu Yuan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:30 PM | Heyman Tomas J. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:30 PM | ROSS ROBERT W. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:05 PM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/25/2023
4:05 PM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad) Nanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront! See how with its ongoing expansion and development |
